NCT04546347View on ClinicalTrials.gov

A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

January 7, 2021

Study Completion Date

January 7, 2021

Conditions
Healthy Volunteers
Interventions
RADIATION

[14C]AZD9833 Solution for Infusion, (NMT 22.8 kBq/5mL)

Dose of \[14C\]AZD9833 Solution for Infusion

DRUG

AZD9833 film-coated tablet A Dose 1

Dose 1 AZD9833 film-coated tablet A Dose 1

DRUG

AZD9833 Oral Solution

AZD9833 Oral Solution

DRUG

AZD9833 film-coated tablet B Dose 1

AZD9833 film-coated tablet B Dose 1

DRUG

AZD9833 film-coated tablet A Dose 2

Dose 1 of AZD9833 film-coated tablet A Dose 2

DRUG

AZD9833 film-coated tablet B Dose 2

Dose 1 of film-coated tablet B Dose 2

Trial Locations (1)

NG11 6JS

Research Site, Ruddington

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Quotient Sciences

INDUSTRY

lead

AstraZeneca

INDUSTRY